KTTAW Analyst Ratings 2026

Pasithea Therapeutics Corp. - Wall Street recommendations & price targets

Consensus Rating

N/A

Current Price

$0.01

Get Complete KTTAW Analysis

AI insights, DCF valuation, and institutional ownership

View Full Analysis

Frequently Asked Questions

What is the analyst rating for KTTAW?

Analyst rating data for KTTAW is being updated. Check back for the latest Wall Street recommendations.

What is the KTTAW price target?

Price target data for KTTAW is being updated.

Is KTTAW a buy according to analysts?

Check the latest analyst recommendations for KTTAW.

How many analysts cover KTTAW?

Analyst coverage information for KTTAW is being updated.

Explore Categories